Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

MKTX vs JPM vs ICE vs CME vs GS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MKTX
MarketAxess Holdings Inc.

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$5.43B
5Y Perf.-70.0%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$825.89B
5Y Perf.+214.8%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$88.45B
5Y Perf.+60.6%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.07B
5Y Perf.+57.1%
GS
The Goldman Sachs Group, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$287.62B
5Y Perf.+371.2%

MKTX vs JPM vs ICE vs CME vs GS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MKTX logoMKTX
JPM logoJPM
ICE logoICE
CME logoCME
GS logoGS
IndustryFinancial - Capital MarketsBanks - DiversifiedFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesFinancial - Capital Markets
Market Cap$5.43B$825.89B$88.45B$104.07B$287.62B
Revenue (TTM)$849M$270.79B$12.64B$6.52B$126.85B
Net Income (TTM)$310M$58.03B$3.30B$4.24B$16.67B
Gross Margin69.9%58.6%61.9%86.1%41.1%
Operating Margin41.2%27.7%38.7%64.9%14.5%
Forward P/E18.6x13.8x19.5x23.5x15.6x
Total Debt$285M$751.15B$20.28B$3.76B$616.93B
Cash & Equiv.$520M$469.32B$837M$4.42B$182.09B

MKTX vs JPM vs ICE vs CME vs GSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MKTX
JPM
ICE
CME
GS
StockMay 20May 26Return
MarketAxess Holding… (MKTX)10030.0-70.0%
JPMorgan Chase & Co. (JPM)100314.8+214.8%
Intercontinental Ex… (ICE)100160.6+60.6%
CME Group Inc. (CME)100157.1+57.1%
The Goldman Sachs G… (GS)100471.2+371.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: MKTX vs JPM vs ICE vs CME vs GS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CME leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. The Goldman Sachs Group, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. JPM and ICE also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
MKTX
MarketAxess Holdings Inc.
The Financial Play

Among these 5 stocks, MKTX doesn't own a clear edge in any measured category.

Best for: financial services exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM ranks third and is worth considering specifically for income & stability and valuation efficiency.

  • Dividend streak 14 yrs, beta 1.00, yield 1.7%
  • PEG 1.06 vs MKTX's 3.03
  • NIM 2.3% vs GS's 0.5%
  • Lower P/E (13.8x vs 23.5x), PEG 1.06 vs 1.71
Best for: income & stability and valuation efficiency
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
  • Beta 0.33, yield 1.2%, current ratio 1.02x
  • Beta 0.33 vs GS's 1.47, lower leverage
Best for: sleep-well-at-night and defensive
CME
CME Group Inc.
The Banking Pick

CME carries the broadest edge in this set and is the clearest fit for quality and dividends.

  • Efficiency ratio 0.2% vs JPM's 0.3% (lower = leaner)
  • 3.8% yield, 6-year raise streak, vs JPM's 1.7%
  • Efficiency ratio 0.2% vs JPM's 0.3%
Best for: quality and dividends
GS
The Goldman Sachs Group, Inc.
The Banking Pick

GS is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 17.0%, EPS growth 77.3%
  • 5.3% 10Y total return vs JPM's 461.3%
  • 17.0% NII/revenue growth vs MKTX's 3.8%
  • +70.6% vs MKTX's -31.7%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGS logoGS17.0% NII/revenue growth vs MKTX's 3.8%
ValueJPM logoJPMLower P/E (13.8x vs 23.5x), PEG 1.06 vs 1.71
Quality / MarginsCME logoCMEEfficiency ratio 0.2% vs JPM's 0.3% (lower = leaner)
Stability / SafetyICE logoICEBeta 0.33 vs GS's 1.47, lower leverage
DividendsCME logoCME3.8% yield, 6-year raise streak, vs JPM's 1.7%
Momentum (1Y)GS logoGS+70.6% vs MKTX's -31.7%
Efficiency (ROA)CME logoCMEEfficiency ratio 0.2% vs JPM's 0.3%

MKTX vs JPM vs ICE vs CME vs GS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MKTXMarketAxess Holdings Inc.
FY 2025
Commission Revenue
86.8%$735M
Information Services
6.3%$53M
Post Trade Services
5.3%$44M
Technology Services
1.6%$14M
JPMJPMorgan Chase & Co.
FY 2024
Consumer & Community Banking
40.3%$71.5B
Commercial And Investment Bank
39.5%$70.1B
Asset and Wealth Management Segment
12.2%$21.6B
Segment Reporting, Reconciling Item, Corporate Nonsegment
9.8%$17.4B
Segment Reconciling Items
-1.7%$-3,037,000,000
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
GSThe Goldman Sachs Group, Inc.
FY 2024
Global Markets
65.3%$34.9B
Investment Management
30.2%$16.1B
Platform Solutions
4.5%$2.4B

MKTX vs JPM vs ICE vs CME vs GS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMKTXLAGGINGICE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

JPM is the larger business by revenue, generating $270.8B annually — 318.9x MKTX's $849M. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to GS's 11.3%.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
RevenueTrailing 12 months$849M$270.8B$12.6B$6.5B$126.9B
EBITDAEarnings before interest/tax$443M$81.3B$6.5B$4.7B$23.4B
Net IncomeAfter-tax profit$310M$58.0B$3.3B$4.2B$16.7B
Free Cash FlowCash after capex$236M-$119.7B$4.3B$4.4B$15.8B
Gross MarginGross profit ÷ Revenue+69.9%+58.6%+61.9%+86.1%+41.1%
Operating MarginEBIT ÷ Revenue+41.2%+27.7%+38.7%+64.9%+14.5%
Net MarginNet income ÷ Revenue+29.0%+21.6%+26.1%+62.0%+11.3%
FCF MarginFCF ÷ Revenue+44.0%-15.5%+33.9%+64.3%-12.1%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+4.5%+16.0%+23.1%+21.4%+45.8%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

JPM leads this category, winning 3 of 7 comparable metrics.

At 15.5x trailing earnings, JPM trades at a 43% valuation discount to ICE's 27.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 1.19x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
Market CapShares × price$5.4B$825.9B$88.4B$104.1B$287.6B
Enterprise ValueMkt cap + debt − cash$5.2B$1.11T$107.9B$103.4B$722.5B
Trailing P/EPrice ÷ TTM EPS22.92x15.51x27.06x25.70x22.84x
Forward P/EPrice ÷ next-FY EPS est.18.63x13.79x19.48x23.49x15.64x
PEG RatioP/E ÷ EPS growth rate3.03x1.19x3.05x1.87x1.63x
EV / EBITDAEnterprise value multiple11.96x13.34x16.71x22.96x34.75x
Price / SalesMarket cap ÷ Revenue6.39x3.05x7.00x15.96x2.27x
Price / BookPrice ÷ Book value/share4.85x2.56x3.08x3.60x2.53x
Price / FCFMarket cap ÷ FCF14.51x20.62x24.82x
JPM leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

MKTX leads this category, winning 6 of 9 comparable metrics.

MKTX delivers a 24.0% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs GS's 4/9, reflecting strong financial health.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
ROE (TTM)Return on equity+24.0%+16.1%+11.6%+15.3%+12.6%
ROA (TTM)Return on assets+15.3%+1.3%+2.3%+2.2%+0.9%
ROICReturn on invested capital+18.1%+5.4%+7.5%+10.2%+1.9%
ROCEReturn on capital employed+25.4%+8.2%+9.5%+3.6%+3.6%
Piotroski ScoreFundamental quality 0–955954
Debt / EquityFinancial leverage0.25x2.18x0.70x0.13x5.06x
Net DebtTotal debt minus cash-$235M$281.8B$19.4B-$666M$434.8B
Cash & Equiv.Liquid assets$520M$469.3B$837M$4.4B$182.1B
Total DebtShort + long-term debt$285M$751.1B$20.3B$3.8B$616.9B
Interest CoverageEBIT ÷ Interest expense168.60x0.74x6.53x41.55x0.31x
MKTX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in GS five years ago would be worth $26,440 today (with dividends reinvested), compared to $3,822 for MKTX. Over the past 12 months, GS leads with a +70.6% total return vs MKTX's -31.7%. The 3-year compound annual growth rate (CAGR) favors GS at 43.5% vs MKTX's -18.6% — a key indicator of consistent wealth creation.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
YTD ReturnYear-to-date-14.1%-5.0%-2.1%+9.1%+1.8%
1-Year ReturnPast 12 months-31.7%+25.2%-10.4%+4.6%+70.6%
3-Year ReturnCumulative with dividends-46.0%+134.6%+50.8%+71.4%+195.2%
5-Year ReturnCumulative with dividends-61.8%+104.3%+43.4%+64.5%+164.4%
10-Year ReturnCumulative with dividends+38.3%+461.3%+225.3%+284.9%+534.3%
CAGR (3Y)Annualised 3-year return-18.6%+32.9%+14.7%+19.7%+43.5%
GS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and GS each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 94.0% from its 52-week high vs MKTX's 65.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
Beta (5Y)Sensitivity to S&P 500-0.28x1.00x0.33x-0.30x1.47x
52-Week HighHighest price in past year$232.84$337.25$189.35$329.16$984.70
52-Week LowLowest price in past year$146.00$248.83$143.17$257.17$547.74
% of 52W HighCurrent price vs 52-week peak+65.6%+90.8%+82.5%+87.1%+94.0%
RSI (14)Momentum oscillator 0–10026.859.438.844.159.5
Avg Volume (50D)Average daily shares traded456K8.3M3.0M2.2M2.0M
Evenly matched — CME and GS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JPM and ICE and CME each lead in 1 of 2 comparable metrics.

Analyst consensus: MKTX as "Hold", JPM as "Buy", ICE as "Buy", CME as "Hold", GS as "Hold". Consensus price targets imply 28.1% upside for MKTX (target: $196) vs 7.6% for GS (target: $996). For income investors, CME offers the higher dividend yield at 3.81% vs ICE's 1.24%.

MetricMKTX logoMKTXMarketAxess Holdi…JPM logoJPMJPMorgan Chase & …ICE logoICEIntercontinental …CME logoCMECME Group Inc.GS logoGSThe Goldman Sachs…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHoldHold
Price TargetConsensus 12-month target$195.60$338.78$195.71$320.25$995.89
# AnalystsCovering analysts2361363555
Dividend YieldAnnual dividend ÷ price+2.0%+1.7%+1.2%+3.8%+1.5%
Dividend StreakConsecutive years of raises121414612
Dividend / ShareAnnual DPS$3.13$5.13$1.93$10.92$13.48
Buyback YieldShare repurchases ÷ mkt cap+7.7%+3.5%+1.6%+0.3%+3.5%
Evenly matched — JPM and ICE and CME each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 1 of 6 categories (Income & Cash Flow). JPM leads in 1 (Valuation Metrics). 2 tied.

Best OverallMarketAxess Holdings Inc. (MKTX)Leads 1 of 6 categories
Loading custom metrics...

MKTX vs JPM vs ICE vs CME vs GS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MKTX or JPM or ICE or CME or GS a better buy right now?

For growth investors, The Goldman Sachs Group, Inc.

(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 3. 8% for MarketAxess Holdings Inc. (MKTX). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 5x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MKTX or JPM or ICE or CME or GS?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 15. 5x versus Intercontinental Exchange, Inc. at 27. 1x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 13. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 06x versus MarketAxess Holdings Inc. 's 3. 03x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — MKTX or JPM or ICE or CME or GS?

Over the past 5 years, The Goldman Sachs Group, Inc.

(GS) delivered a total return of +164. 4%, compared to -61. 8% for MarketAxess Holdings Inc. (MKTX). Over 10 years, the gap is even starker: GS returned +534. 3% versus MKTX's +38. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MKTX or JPM or ICE or CME or GS?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately -582% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MKTX or JPM or ICE or CME or GS?

By revenue growth (latest reported year), The Goldman Sachs Group, Inc.

(GS) is pulling ahead at 17. 0% versus 3. 8% for MarketAxess Holdings Inc. (MKTX). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to -8. 5% for MarketAxess Holdings Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MKTX or JPM or ICE or CME or GS?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 11. 3% for The Goldman Sachs Group, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 5% for GS. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MKTX or JPM or ICE or CME or GS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 06x versus MarketAxess Holdings Inc. 's 3. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 13. 8x forward P/E versus 23. 5x for CME Group Inc. — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MKTX: 28. 1% to $195. 60.

08

Which pays a better dividend — MKTX or JPM or ICE or CME or GS?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 1. 2% for Intercontinental Exchange, Inc. (ICE).

09

Is MKTX or JPM or ICE or CME or GS better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Both have compounded well over 10 years (CME: +284. 9%, GS: +534. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MKTX and JPM and ICE and CME and GS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MKTX is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MKTX

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 17%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

JPM

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 12%
Run This Screen
Stocks Like

ICE

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 15%
Run This Screen
Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Stocks Like

GS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MKTX and JPM and ICE and CME and GS on the metrics below

Revenue Growth>
%
(MKTX: 3.8% · JPM: 14.6%)
Net Margin>
%
(MKTX: 29.0% · JPM: 21.6%)
P/E Ratio<
x
(MKTX: 22.9x · JPM: 15.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.